United Kingdom  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Sanofi pulls Zantac from U.S. and Canada after carcinogen found

Reuters Friday, 18 October 2019
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

FDA: No Carcinogens In OTC Heartburn Meds [Video]FDA: No Carcinogens In OTC Heartburn Meds

Zantac and its generic versions, known chemically as ranitidine, are popular heartburn medicines. Reuters reports they have not been found to contain the carcinogen that ranitidine has been linked to...

Credit: Wochit News     Duration: 00:46Published


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.